Chronic Lymphocytic Leukemia in Adults

Our oncologists, hematologists, and pathologists use advanced diagnostic tools and the latest treatments to manage chronic lymphocytic leukemia, a cancer of the blood and bone marrow that typically progresses slowly. Our specialists provide ongoing monitoring, care, and support to help you live with this chronic disease. We can also determine whether you can be monitored and delay treatment safely, or if you need to start tailored regimens of chemotherapy and newly approved targeted therapy to manage the condition.

Clinical Trials and Research Studies

Phase 1

A PHASE 1 STUDY OF MILADEMETAN IN COMBINATION WITH QUIZARTINIB IN SUBJECTS WITH FLT3-ITD MUTANT ACUTE MYELOID LEUKEMIA THAT ARE RELAPSED/REFRACTORY OR NEWLY DIAGNOSED AND UNFIT FOR INTENSIVE CHEMOTHERAPY

Learn More

Phase 2

AAML18P1: Stopping Tyrosine Kinase Inhibitors (TKI) to Assess Treatment-Free Remission (TFR) in Pediatric Chronic Myeloid Leukemia - Chronic Phase (CML-CP)

Learn More

Phase 3

AALL1631: International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Ph+ ALL Testing Imatinib in Combination with Two Different Cytotoxic Chemotherapy Backbones

Learn More

Phase 3

AALL1731: A Phase 3 Trial Investigating Blinatumomab (IND# 117467 NSC# 765986) in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients with Localized B-Lymphoblastic Lymphoma (B-LLy)

Learn More